1,5-isoquinolinediol increases the frequency of gene targeting by homologous recombination in mouse fibroblasts

Citations Over Time

Abstract

Gene targeting is a technique that allows the introduction of predefined alterations into chromosomal DNA. It involves a homologous recombination reaction between the targeted genomic sequence and an exogenous targeting vector. In theory, gene targeting constitutes the ideal method of gene therapy for single gene disorders. In practice, gene targeting remains extremely inefficient for at least two reasons: very low frequency of homologous recombination in mammalian cells and high proficiency of the mammalian cells to randomly integrate the targeting vector by illegitimate recombination. One known method to improve the efficiency of gene targeting is inhibition of poly(ADP-ribose)polymerase (PARP). It has been shown that PARP inhibitors, such as 3-methoxybenzamide, could lower illegitimate recombination, thus increasing the ratio of gene targeting to random integration. However, the above inhibitors were reported to decrease the absolute frequency of gene targeting. Here we show that treatment of mouse Ltk cells with 1,5-isoquinolinediol, a recent generation PARP inhibitor, leads to an increase up to 8-fold in the absolute frequency of gene targeting in the correction of the mutation at the stable integrated HSV tk gene.

Related Papers

• → Analysis of DNA double-strand break repair pathways in mice(2006)72 cited
• → Homologous recombination and nonhomologous end-joining repair in yeast(2021)1 cited
• → Homologous junctions formed between a vector and human genomic repetitive line-1 elements as a result of one-sided invasion(1997)7 cited
• → Genetic reporters to detect and quantify homologous recombination in yeast(2022)